M&A Deal Summary |
|
|---|---|
| Date | 2021-06-22 |
| Target | SIRION Biotech |
| Sector | Life Science |
| Buyer(s) | Revvity |
| Deal Type | Add-on Acquisition |
SEARCH BY
| Category | Company |
|---|---|
| Founded | 1937 |
| Sector | Medical Products |
| Employees | 11,000 |
| Revenue | 2.8B USD (2024) |
Revvity provides health science solutions, technologies, expertise and services that deliver complete workflows from discovery to development, and diagnosis to cure. Revvity is revolutionizing what’s possible in healthcare, with specialized focus areas in translational multi-omics technologies, biomarker identification, imaging, prediction, screening, detection and diagnosis, informatics and more. Revvity was formed in 1937 and is based in Waltham, Massachusetts.
| DEAL STATS | # |
|---|---|
| Overall | 35 of 37 |
| Sector: Life Science M&A | 7 of 8 |
| Type: Add-on Acquisition M&A Deals | 33 of 35 |
| Country: Germany M&A | 4 of 4 |
| Year: 2021 M&A | 4 of 5 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2021-05-17 |
Immunodiagnostic Systems
Boldon, United Kingdom Immunodiagnostic Systems is engages in the development, manufacture, and marketing of in-vitro diagnostic tests (IVD) to the clinical laboratory market. It operates through the following business units: Automated IVD Business, Manual IVD Business, and Licensing and Technology. Immunodiagnostic Systems was founded in 1977 and is headquartered in Boldon, the United Kingdom. |
Buy | $155M |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2021-07-26 |
BioLegend
San Diego, California, United States BioLegend is a provider of life science antibodies and reagents for biomedical research. BioLegend is based in San Diego, California. |
Buy | $5.3B |
